TWST
HOLD / NEUTRALMeanRevComposite
48.80
Technical
77.70
Fundamental
39.20
Rank
—
Price
159.85
Hurst
0.36
As of
Oct 28, 2026
Daily
Twist Bioscience Corporation
HealthcareBiotechnologyTwist Bioscience manufactures synthetic DNA products for use across multiple industries including pharmaceuticals, diagnostics, agriculture, and academic research. Its portfolio includes synthetic genes and oligonucleotide pools for applications such as gene editing and next-generation sequencing, as well as diagnostic kits for disease detection and research. The company also produces viral reference materials and antibody engineering tools for drug development purposes.
Market cap
$10.1B
P/E (trailing)
—
P/E (forward)
-381.95
PEG ratio
—
Dividend yield
0.00%
Beta
2.19
52w range
23.30 – 219.71
Return on equity
-29.59%
Profit margin
-31.66%
Revenue growth
+23.20%
Earnings growth
—
Price history
1Y: 152.78 (+364.5%) · range 25.45–205.00
Cycle position
54/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 19 · NOT READY · exit proximity 35
Conviction
34/ 100 · maturity 100%
VScore.4030
Buildup.2055
EMA entry setup.2519
Fundamentals.1539
Volume profile
POC
90.93
Price vs POC
+68.0%
Overhead supply
27%
Runway
open sky
Value area 48.00–151.03 · 27% of 120d volume overhead · moderate overhead
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.459 | Oct 29, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -16.20% | -4.31% | 13/20d |
| 40d | -16.20% | -4.31% | 13/40d |